The Manila Times1j yang laluLUNR Aerospace Corporation Obtains Receipt for Final Prospectus Accessible on SEDAR+TORONTO, Oct. 23, 2026 (GLOBE NEWSWIRE) -- LUNR Aerospace Corporation (the 'Corporation” or 'LUNR”) is pleased to announce that it has obtained a receipt for its final long form prospectus dated October 22, 2026 (the 'Prospectus”) from the Ontario Securities Commission qualifying the distribution of 7,925,925 common shares in the capital of the Corporation (the 'Common Shares”) issuable upon the automatic conversion of previously issued subscription receipts of the Corporation. Hampton Securitie1j yang lalu
MarketScreener1j yang laluMaterials Down as Precious Metal Selloff Continues Materials RoundupProducers of metals, grains and other raw materials fell as the U.S. dollar neared multiyear highs ahead of the Federal Reserve's October meeting. Dollar-sensitive precious metals continued a...1j yang lalu
MarketScreener2j yang laluBingung soal Valuasi? Pasar pun SamaIndeks S&P 500 ditutup melemah pekan ini. Pelemahan itu terbebani oleh kinerja perusahaan yang beragam, kekhawatiran atas saham-saham terkait AI, serta kenaikan harga minyak.2j yang lalu
Seeking Alpha2j yang laluCerebras: I Waited For This Entry PointCerebras Systems Inc. stock is down 69%, but revenue, RPO, and cash are soaring. Click here to read this bullish analysis of the CBRS stock.2j yang lalu
WTOP3j yang laluMetroCity Merilis Laporan Laba Kuartal IIIPerusahaan membukukan laba per saham 84 sen. Pendapatan pada periode tersebut mencapai $74,1 juta.3j yang lalu
Times of India3j yang lalu₹9,260 a quintal for cotton, but El Nino threatens yieldsCotton prices in Adilabad hit ₹9,260/quintal above MSP, but dry weather and El Niño fears may cut yields; CCI procurement delayed over moisture.3j yang lalu
Free Press Journal5j yang laluTorrent Pharma Profit Falls 9.6 Per Cent, Dr Reddy’s Slumps 36 Pc In Q2 FY27Torrent Pharmaceuticals’ Q2 FY27 net profit fell 9.6% to Rs 534 crore, although revenue rose 50.8% to Rs 4,979 crore as expenses climbed 70.9%. Dr Reddy’s Laboratories reported a 36% profit decline to Rs 913.4 crore; revenue slipped 1.5% to Rs 8,671 crore and EBITDA fell 24.2% to Rs 1,783 crore, with its margin narrowing to 20.6%.5j yang lalu
OilPrice5j yang laluLaba SLB Lampaui Perkiraan seiring Pemulihan Pengeboran di Timur TengahLaba per saham disesuaikan perusahaan mencapai US$0,64, di atas ekspektasi US$0,62. Pendapatan naik 6% secara tahunan menjadi US$9,45 miliar.5j yang lalu